CVE:MFS Medifocus Inc. (MFS.V) (MFS) Stock Price, News & Analysis C$0.01 0.00 (0.00%) As of 09/4/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Medifocus Inc. (MFS.V) Stock (CVE:MFS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medifocus Inc. (MFS.V) alerts:Sign Up Key Stats Today's RangeC$0.01▼C$0.0150-Day RangeC$0.01▼C$0.0152-Week RangeC$0.01▼C$0.02Volume26,000 shsAverage Volume317,764 shsMarket CapitalizationC$1.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada. Read More Receive MFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifocus Inc. (MFS.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address MFS Stock News HeadlinesMFS Growth R6 MFEKXSeptember 21, 2024 | morningstar.comMMFS Research A MFRFXSeptember 12, 2024 | morningstar.comM$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.July 8 at 2:00 AM | Brownstone Research (Ad)MFS Research I MRFIXSeptember 11, 2024 | morningstar.comMMFS Intl Diversification AAugust 9, 2024 | morningstar.comMInsuraGuest Technologies Inc. (ISGI.V)March 21, 2024 | ca.finance.yahoo.comVior Inc. (VIO.V)February 18, 2024 | ca.finance.yahoo.comBeacn Wizardry and Magic Inc. (BECN.V)December 30, 2023 | ca.finance.yahoo.comSee More Headlines MFS Stock Analysis - Frequently Asked Questions How have MFS shares performed this year? Medifocus Inc. (MFS.V)'s stock was trading at C$0.01 at the start of the year. Since then, MFS stock has increased by 0.0% and is now trading at C$0.01. How do I buy shares of Medifocus Inc. (MFS.V)? Shares of MFS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Medifocus Inc. (MFS.V) own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medifocus Inc. (MFS.V) investors own include (RLYP) (RLYP), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE) and Chevron (CVX). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryMachinery Current SymbolCVE:MFS CIKN/A Webwww.medifocusinc.com Phone+1-905-3197070FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.04 Quick Ratio0.03 Sales & Book Value Annual SalesC$2.23 million Price / Sales0.83 Cash FlowC$0.00 per share Price / Cash Flow10.00 Book ValueC($0.07) per share Price / Book-0.15Miscellaneous Outstanding Shares184,984,000Free FloatN/AMarket CapC$1.85 million OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (CVE:MFS) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifocus Inc. (MFS.V) Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifocus Inc. (MFS.V) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.